BNP PARIBAS FINANCIAL MARKETS - DYNAVAX TECHNOLOGIES CORP ownership

DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158102. A total of 96 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of DYNAVAX TECHNOLOGIES CORP
ValueSharesWeighting
Q3 2014$22,129,000
+858.4%
15,475
+972.4%
0.00%
Q2 2014$2,309,000
-64.6%
1,443
-56.6%
0.00%
Q4 2013$6,523,000
-89.0%
3,328
-93.3%
0.00%
Q3 2013$59,389,000
-16.1%
49,907
-22.5%
0.00%
Q2 2013$70,791,00064,3550.00%
Other shareholders
DYNAVAX TECHNOLOGIES CORP shareholders Q2 2013
NameSharesValueWeighting ↓
HealthCor Management, L.P. 17,600,000$19,360,0001.17%
RA Capital Management 6,000,000$6,600,0000.88%
WEXFORD CAPITAL LP 4,054,410$4,460,0000.39%
Orbimed Advisors 8,986,000$9,885,0000.21%
HOWARD HUGHES MEDICAL INSTITUTE 433,557$477,0000.16%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,814,986$1,978,0000.12%
FEDERATED HERMES, INC. 26,015,167$28,617,0000.11%
Amici Capital, LLC 1,800,000$1,980,0000.07%
KENNEDY CAPITAL MANAGEMENT LLC 1,240,448$1,364,0000.03%
SAC Capital Advisors LP 3,827,918$4,211,0000.02%
View complete list of DYNAVAX TECHNOLOGIES CORP shareholders